Envoy Medical secures $4M upfront in direct offering, targets total $16M via warrant exercise

Envoy Medical (NASDAQ:COCH [https://seekingalpha.com/symbol/COCH]) has announced it has entered into definitive agreements for a new capital raise [https://seekingalpha.com/pr/20258473-envoy-medical-announces-up-to-16-million-registered-direct-offering-priced-at-the-market], for issuance and sell an aggregate of 3,007,524 shares of Class A common stock in a registered direct offering priced at $1.33 per share.

In a concurrent private placement, Envoy Medical will also issue and sell unregistered warrants to purchase up to 9,022,572 shares of Class A common stock.

These warrants have an exercise price of $1.33 per share, are immediately exercisable, and will expire 24 months after the effective date of the resale registration statement.

The offering is expected to close on or about October 9, 2025.

The gross proceeds to Envoy Medical from the initial sale of common stock are expected to be approximately $4.0 million.

The unregistered warrants represent a potential source of additional capital, which could generate approximately $12 million in gross proceeds if fully exercised for cash.

Envoy Medical intends to use the net proceeds from the offering for working capital and general corporate purposes.

MORE ON ENVOY MEDICAL

* Envoy Medical announces $2.5 million registered direct offering priced at-the-market under Nasdaq rules [https://seekingalpha.com/news/4497026-envoy-medical-announces-25-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules]
* Seeking Alpha’s Quant Rating on Envoy Medical [https://seekingalpha.com/symbol/COCH/ratings/quant-ratings]
* Historical earnings data for Envoy Medical [https://seekingalpha.com/symbol/COCH/earnings]
* Financial information for Envoy Medical [https://seekingalpha.com/symbol/COCH/income-statement]